GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML) - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
88127445
Word Mark
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2021-05-10
Filing Date
2018-09-21
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261113, 261121, 261125, 261709 - Two rectangles. Rectangles that are completely or partially shaded. Rectangles with one or more curved sides. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2019-01-29
Attorney Name
Law Office Assigned Location Code
N40
Employee Name
GANESH, HARINI
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)"
Description of Mark
The mark consists of a rectangle surrounding the word "GEMCITABINE" above the words "in 0.9% sodium chloride injection" along with an arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle, with the words "mg per mL (10 mg/mL)".
Goods and Services
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Goods and Services
medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-09-28
Primary Code
005
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-09-28
Primary Code
010
First Use Anywhere Date
2020-07-08
First Use In Commerce Date
2020-07-08
Correspondences
Name
Craig Kuchii, Esq.
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2018-09-25 | NEW APPLICATION ENTERED IN TRAM |
| 2018-09-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-09-29 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2018-11-28 | ASSIGNED TO EXAMINER |
| 2018-11-29 | EXAMINERS AMENDMENT -WRITTEN |
| 2018-11-29 | EXAMINERS AMENDMENT E-MAILED |
| 2018-11-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2018-11-29 | EXAMINER'S AMENDMENT ENTERED |
| 2018-11-30 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-12-21 | ASSIGNED TO LIE |
| 2019-01-09 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-01-29 | PUBLISHED FOR OPPOSITION |
| 2019-01-29 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-03-26 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-09-23 | TEAS EXTENSION RECEIVED |
| 2019-09-23 | EXTENSION 1 FILED |
| 2019-09-23 | EXTENSION 1 GRANTED |
| 2019-09-25 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-03-24 | TEAS EXTENSION RECEIVED |
| 2020-03-24 | EXTENSION 2 FILED |
| 2020-03-24 | EXTENSION 2 GRANTED |
| 2020-03-26 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-09-24 | TEAS STATEMENT OF USE RECEIVED |
| 2020-09-24 | TEAS EXTENSION RECEIVED |
| 2020-09-30 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2020-09-24 | EXTENSION 3 FILED |
| 2020-09-30 | EXTENSION 3 GRANTED |
| 2020-09-24 | USE AMENDMENT FILED |
| 2020-09-30 | STATEMENT OF USE PROCESSING COMPLETE |
| 2020-10-01 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-10-22 | SU - NON-FINAL ACTION - WRITTEN |
| 2020-10-22 | NON-FINAL ACTION E-MAILED |
| 2020-10-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-05-10 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2021-05-10 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
